DSM: 2017 outlook raised on back of 'positive momentum'
(CercleFinance.com) - DSM, a Dutch life sciences company which is active in health, nutrition and materials, said that it maintained a positive momentum in the first half of the year, with performance well ahead of targets.
DSM reported earnings before interest, tax, depreciation and amortisation (adjusted EBITDA) that was up 16% at 721 million euros, driven by both nutrition and materials.
Its sales grew by 11% to 4.32 billion euros, up 8% in organic terms.
The group said it was confident for the remainder of the year and has increased its outlook for the full year.
DSM now expects to deliver full-year 2017 results above the targets set out in its "Strategy 2018" plan, with EBITDA growth for the year moving slightly up from "high single-digit" to "double digit".
The shares were jumping 5.5% at 65.8 euros on Euronext Amsterdam after the report.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
DSM reported earnings before interest, tax, depreciation and amortisation (adjusted EBITDA) that was up 16% at 721 million euros, driven by both nutrition and materials.
Its sales grew by 11% to 4.32 billion euros, up 8% in organic terms.
The group said it was confident for the remainder of the year and has increased its outlook for the full year.
DSM now expects to deliver full-year 2017 results above the targets set out in its "Strategy 2018" plan, with EBITDA growth for the year moving slightly up from "high single-digit" to "double digit".
The shares were jumping 5.5% at 65.8 euros on Euronext Amsterdam after the report.
Copyright (c) 2017 CercleFinance.com. All rights reserved.